Rural Health
Resources by Topic: Prescription drug misuse
Death by Drugs: Colorado Reaches a Record High for Overdose Fatalities. Again.
Describes county-level estimates for drug overdose death rates in Colorado from 2001 through 2016 using data from the Colorado Department of Public Health and Environment (CDPHE). Includes discussion on small counties experiencing high overdose rates, the rise of opioid overdoses and deaths, and covers policy implications.
Additional links: Full Report
Author(s): Jaclyn Zubrzycki
Date: 04/2018
Type: Document
Sponsoring organization: Colorado Health Institute
view details
Describes county-level estimates for drug overdose death rates in Colorado from 2001 through 2016 using data from the Colorado Department of Public Health and Environment (CDPHE). Includes discussion on small counties experiencing high overdose rates, the rise of opioid overdoses and deaths, and covers policy implications.
Additional links: Full Report
Author(s): Jaclyn Zubrzycki
Date: 04/2018
Type: Document
Sponsoring organization: Colorado Health Institute
view details
Patterns of Opioid Prescribing in Minnesota: 2012 and 2015
Describes opioid prescription patterns among Minnesota residents with private or public insurance coverage in 2012 and 2015. Discusses opioid use in rural areas and provides statistics on the number of opioid prescriptions by metropolitan, micropolitan, small town, or rural settings. Includes insights and opportunities to inform policymakers on reducing the use and overuse of prescription opioids.
Date: 04/2018
Type: Document
Sponsoring organization: Minnesota Department of Health
view details
Describes opioid prescription patterns among Minnesota residents with private or public insurance coverage in 2012 and 2015. Discusses opioid use in rural areas and provides statistics on the number of opioid prescriptions by metropolitan, micropolitan, small town, or rural settings. Includes insights and opportunities to inform policymakers on reducing the use and overuse of prescription opioids.
Date: 04/2018
Type: Document
Sponsoring organization: Minnesota Department of Health
view details
Combating the Opioid Crisis: Improving the Ability of Medicare and Medicaid to Provide Care for Patients
Presents the U.S. House of Representatives Energy and Commerce Committee hearing on the role of Medicare and Medicaid in combating the opioid crisis. Features testimony from representatives of Centers for Medicare and Medicaid Services, Boston Medical Center, the Centene Corporation, Centerstone America, Geisinger Health System, and Magellan Healthcare.
Additional links: Mr. David Guth Testimony, Mr. Toby Douglas Testimony
Date: 04/2018
Type: Video/Multimedia
Sponsoring organization: House Committee on Energy and Commerce
view details
Presents the U.S. House of Representatives Energy and Commerce Committee hearing on the role of Medicare and Medicaid in combating the opioid crisis. Features testimony from representatives of Centers for Medicare and Medicaid Services, Boston Medical Center, the Centene Corporation, Centerstone America, Geisinger Health System, and Magellan Healthcare.
Additional links: Mr. David Guth Testimony, Mr. Toby Douglas Testimony
Date: 04/2018
Type: Video/Multimedia
Sponsoring organization: House Committee on Energy and Commerce
view details
Opioid White Paper: Analysis of Responses to Committee Request for Information
Details an analysis of the information received by the U.S. House of Representatives Ways and Means Committee regarding the opioid crisis. Discusses the current state of the crisis and the measures currently in place regarding prevention and treatment.
Date: 04/2018
Type: Document
Sponsoring organization: House Ways and Means Committee
view details
Details an analysis of the information received by the U.S. House of Representatives Ways and Means Committee regarding the opioid crisis. Discusses the current state of the crisis and the measures currently in place regarding prevention and treatment.
Date: 04/2018
Type: Document
Sponsoring organization: House Ways and Means Committee
view details
The Opioid Crisis Response Act of 2018
Presents the U.S. Senate Committee on Health, Education, Labor, and Pensions (HELP) hearing on the Opioid Crisis Response Act of 2018. Features testimony from representatives of the Delaware Office of the Child Advocate, the National Association of State Alcohol and Drug Abuse Directors, and the Addiction Policy Forum.
Date: 04/2018
Type: Video/Multimedia
Sponsoring organization: Senate Committee on Health, Education, Labor & Pensions
view details
Presents the U.S. Senate Committee on Health, Education, Labor, and Pensions (HELP) hearing on the Opioid Crisis Response Act of 2018. Features testimony from representatives of the Delaware Office of the Child Advocate, the National Association of State Alcohol and Drug Abuse Directors, and the Addiction Policy Forum.
Date: 04/2018
Type: Video/Multimedia
Sponsoring organization: Senate Committee on Health, Education, Labor & Pensions
view details
Moving Away from the Tip of the Pyramid: Screening and Brief Intervention for Risky Alcohol and Opioid Use in Underserved Patients
Summarizes the findings of an online survey of a practice-based research network of 126 medical providers serving Hispanic/Latino and Native American patients in rural and urban settings in New Mexico. Discusses clinician perspectives on the need to address substance use in primary care, current screening and treatment practices, and their willingness to adapt practices to meet the needs of the patient populations.
Author(s): Kamilla L. Venner, Victoria Sánchez, Jacqueline Garcia, et al.
Citation: Journal of the American Board of Family Medicine, 31(2), 243-251
Date: 03/2018
Type: Document
view details
Summarizes the findings of an online survey of a practice-based research network of 126 medical providers serving Hispanic/Latino and Native American patients in rural and urban settings in New Mexico. Discusses clinician perspectives on the need to address substance use in primary care, current screening and treatment practices, and their willingness to adapt practices to meet the needs of the patient populations.
Author(s): Kamilla L. Venner, Victoria Sánchez, Jacqueline Garcia, et al.
Citation: Journal of the American Board of Family Medicine, 31(2), 243-251
Date: 03/2018
Type: Document
view details
Understanding the Science of Pain and Opioids
An overview of how opioids impact the brain and of the brain disease model of opioid use disorder. Includes a list of risk factors related to drug misuse.
Author(s): Kay Miller Temple
Citation: Rural Monitor
Date: 03/2018
Type: Document
Sponsoring organization: Rural Health Information Hub
view details
An overview of how opioids impact the brain and of the brain disease model of opioid use disorder. Includes a list of risk factors related to drug misuse.
Author(s): Kay Miller Temple
Citation: Rural Monitor
Date: 03/2018
Type: Document
Sponsoring organization: Rural Health Information Hub
view details
The "M" of MAT: Medications for Opioid Use Disorder
A brief overview of medications used to treat opioid use disorder, as part of whole-patient treatment which includes counseling and behavioral therapies.
Author(s): Kay Miller Temple
Citation: Rural Monitor
Date: 03/2018
Type: Document
Sponsoring organization: Rural Health Information Hub
view details
A brief overview of medications used to treat opioid use disorder, as part of whole-patient treatment which includes counseling and behavioral therapies.
Author(s): Kay Miller Temple
Citation: Rural Monitor
Date: 03/2018
Type: Document
Sponsoring organization: Rural Health Information Hub
view details
Combating the Opioid Crisis: Prevention and Public Health Solutions
Presents the U.S. House of Representatives Energy and Commerce Committee hearing on preventative measures and the role of public health in combating the opioid crisis. Features testimony from representatives of the Food and Drug Administration, Centers for Disease Control and Prevention, Substance Abuse and Mental Health Services, the National Association of County and City Health Officials, and the National Indian Health Board, among others.
Additional links: Michael E. Kilkenny Testimony, Stacy Bohlen Testimony
Date: 03/2018
Type: Video/Multimedia
Sponsoring organization: House Energy and Commerce Committee, Subcommittee on Health
view details
Presents the U.S. House of Representatives Energy and Commerce Committee hearing on preventative measures and the role of public health in combating the opioid crisis. Features testimony from representatives of the Food and Drug Administration, Centers for Disease Control and Prevention, Substance Abuse and Mental Health Services, the National Association of County and City Health Officials, and the National Indian Health Board, among others.
Additional links: Michael E. Kilkenny Testimony, Stacy Bohlen Testimony
Date: 03/2018
Type: Video/Multimedia
Sponsoring organization: House Energy and Commerce Committee, Subcommittee on Health
view details
The Geographic Variation in the Cost of the Opioid Crisis
Presents a study on the economic costs of the opioid crisis across the nation. Features state-by-state and county-level data on the monetary burden of opioid abuse on communities.
Author(s): Alex Brill, Scott Ganz
Date: 03/2018
Type: Document
Sponsoring organization: American Enterprise Institute
view details
Presents a study on the economic costs of the opioid crisis across the nation. Features state-by-state and county-level data on the monetary burden of opioid abuse on communities.
Author(s): Alex Brill, Scott Ganz
Date: 03/2018
Type: Document
Sponsoring organization: American Enterprise Institute
view details